Financials Trident Lifeline Limited

Equities

543616

INE0MKA01014

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:54 2024-05-24 am EDT 5-day change 1st Jan Change
169 INR -5.59% Intraday chart for Trident Lifeline Limited -3.84% -10.11%

Valuation

Fiscal Period: Maart 2023
Capitalization 1 1,830
Enterprise Value (EV) 1 1,748
P/E ratio 25.5 x
Yield -
Capitalization / Revenue 5.77 x
EV / Revenue 5.52 x
EV / EBITDA 27 x
EV / FCF -7,293,350 x
FCF Yield -0%
Price to Book 4.01 x
Nbr of stocks (in thousands) 11,499
Reference price 2 159.1
Announcement Date 8/23/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Maart 2022 2023
Net sales 1 217.7 316.9
EBITDA 1 27.61 64.66
EBIT 1 25.59 61.01
Operating Margin 11.75% 19.25%
Earnings before Tax (EBT) 1 30.28 65.78
Net income 1 22.49 60.15
Net margin 10.33% 18.98%
EPS 2 3.940 6.228
Free Cash Flow - -239.7
FCF margin - -75.63%
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 8/1/22 8/23/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2022 2023
Net Debt 1 23.2 -
Net Cash position 1 - 81.5
Leverage (Debt/EBITDA) 0.8415 x -
Free Cash Flow - -240
ROE (net income / shareholders' equity) - 23.9%
ROA (Net income/ Total Assets) - 10.5%
Assets 1 - 573.2
Book Value Per Share 2 5.970 39.70
Cash Flow per Share 2 0.1600 12.00
Capex 1 4.55 46.4
Capex / Sales 2.09% 14.65%
Announcement Date 8/1/22 8/23/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 543616 Stock
  4. Financials Trident Lifeline Limited